Regeneron gets Libtayo approval in Japan for advanced cervical cancer
Regeneron Pharmaceuticals has secured the approval of the Japanese Ministry of Health, Labor and Welfare (MHLW) to manufacture and market the company’s Libtayo (cemiplimab) for ... Read More
KKR to acquire Japanese CDMO Bushu Pharmaceuticals from BPEA EQT
American global investment company Kohlberg Kravis Roberts & Co (KKR) will acquire all shares of Bushu Pharmaceuticals from Asian private equity firm BPEA EQT for ... Read More
Aflac, Trupanion to establish pet insurance joint venture in Japan
Aflac Incorporated, through its subsidiary Aflac Life Insurance Japan, and Trupanion will set up a pet insurance joint venture (JV) in Japan under the name ... Read More
Kioxia, Western Digital open new semiconductor fab in Yokkaichi
Kioxia, a Japanese computer memory manufacturer, and Western Digital, an American computer hard disk drive manufacturer and data storage company, have opened a new semiconductor ... Read More
Biocon Biologics signs licensing deal for two biosimilars with Yoshindo
Biocon Ltd. said that its subsidiary Biocon Biologics has signed an out-licensing agreement with Japanese pharma company Yoshindo Inc. for commercializing a couple of its ... Read More
Gravita India begins production from aluminium recycling plant in Senegal
Gravita India Limited, an Indian recycling company, announced that it has begun commercial production of aluminium at its new recycling plant in Senegal through its ... Read More
Wipro names new Japan country head and MD in Dhruv Anand
Indian IT services provider Wipro has appointed Dhruv Anand as the company’s new country head and managing director for its Japanese operations. According to Wipro, ... Read More
Toyoda Gosei begins production at Miyagi Ohira Plant
Toyoda Gosei said that its subsidiary Toyoda Gosei East Japan has commenced production of large plastic automotive parts at its Miyagi Ohira Plant in Miyagi, ... Read More
Lenskart acquires majority stake in Japanese eyewear brand Owndays
Lenskart, an Indian prescription eyewear retail chain, has reportedly acquired a majority stake in Owndays, a Japanese direct-to-customer (D2C) eyewear brand, for $400m. The deal ... Read More
Cullinan Oncology to sell Cullinan Pearl to Taiho Pharmaceutical for $275m
American biopharma company Cullinan Oncology has agreed to sell its subsidiary Cullinan Pearl to Taiho Pharmaceutical, a Japanese specialty pharma company, for $275 million. Cullinan ... Read More